Afib and Heart Failure Together: What Does It Mean, and What Can You Do?

doctor checking patient's heart

For patients diagnosed with atrial fibrillation (Afib), there's something that’s not always fully apparent: Afib doesn't just affect your heart rhythm—it can lead directly to heart failure, which happens to be the leading cause of death in Afib patients.2

A Tale of Two Conditions That Encourage Each Other

Think of Afib and heart failure as partners that are up to no good. They don't just coexist—they actively make each other worse, creating what cardiologists call a "vicious cycle."1

How Afib Damages Your Heart

When the heart beats irregularly due to Afib, several negative things happen:

  • Loss of coordinated pumping: The atria (upper chambers) stop contributing effectively to filling the ventricles
  • Reduced filling time: The irregular, often rapid rhythm doesn't give your heart enough time to fill with blood
  • Decreased cardiac output: Less blood gets pumped out to the body with each heartbeat
  • Increased pressure: The backup effect increases pressure throughout your cardiovascular system

The Progression

This initial damage triggers the body's stress response systems, which can make things worse by:

  • Stretching your left atrium
  • Increasing atrial pressure and size
  • Creating scar tissue (fibrosis) in your heart
  • Generating more abnormal electrical triggers
  • Slowing down normal electrical conduction

How does that progress? Afib gets worse, heart function deteriorates, and the cycle accelerates.

The Numbers That Tell the Story

The statistics surrounding Afib and heart failure are serious:

  • After age 40: 1 in 4 people will develop Afib,6 and 1 in 5 will develop heart failure7
  • Risk multiplier: Having Afib makes you 5 times more likely to develop heart failure10
  • Mortality reality: 29% of Afib patients die of heart failure within a decade of diagnosis2
  • Economic impact: Heart failure costs are expected to double to $70 billion by 20301

More importantly, these numbers represent millions of people whose lives could be improved with the right Afib treatment.

Hiding in Plain Sight – Shared Risk Factors

Part of what makes this relationship so dangerous is that Afib and heart failure often share the same underlying risk factors:9

  • Hypertension
  • Diabetes
  • Obesity
  • Sleep apnea
  • Aging
  • Genetics
  • Chronic inflammation

This overlap means that by the time symptoms appear, both conditions may already be silently progressing.1

The Golden Opportunity: Surgical Intervention

There’s a great reason to be optimistic, though. For patients already having structural heart surgery—such as a valve repair or coronary artery bypass—that’s the golden opportunity to address Afib in the same procedure.

However, despite clear medical guidelines recommending Afib treatment during cardiac surgery and multiple studies showing the long-term survival benefits, Afib is ignored almost 80% of the time in patients already undergoing heart surgery.3-4 This represents thousands of missed opportunities each year to prevent future heart failure and improve patient outcomes.

The Evidence to Justify Acting

Research consistently shows that patients with Afib who receive surgical ablation during their cardiac procedure have:4, 11

  • Improved long-term survival without increased surgical risk
  • Better quality of life after surgery
  • Return to normal life expectancy curves when sinus rhythm is restored
  • Less functional impairment when they maintain normal rhythm8

What Restoring Normal Rhythm Means

When surgeons successfully restore normal heart rhythm by treating it during cardiac surgery, it’s similar to hitting the reset button on the Afib-heart failure cycle. Patients who spend more time in normal sinus rhythm experience:

  • Improved exercise capacity
  • Reduced hospitalizations
  • Better overall heart function
  • Decreased stroke risk
  • Enhanced quality of life

Most importantly, treating Afib surgically can put patients back on the same life-expectancy curve as if they never had Afib in the first place.11

 

Breaking the Cycle: What Patients Can Do

Before Surgery

If you're scheduled for cardiac surgery and have Afib:

  1. Ask specifically about concurrent Afib treatment
  2. Request consultation with an electrophysiologist if your surgeon seems hesitant
  3. Understand the risks of leaving Afib untreated versus treating it
  4. Advocate for yourself—you may need to be persistent

Conversation Starters:

  • "I understand Afib increases my risk of heart failure. Is it possible to address both issues during my surgery?"
  • "What are the long-term consequences if we don't treat my Afib now?"
  • "Can you explain any reasons why surgical Afib treatment might not be recommended in my case?"

The Bigger Picture: A Healthcare System Challenge

The undertreatment of Afib during cardiac surgery also represents a broader healthcare challenge. Despite strong evidence and clear guidelines, implementation remains inconsistent. This may be due to:

  • Perceived complexity of the additional procedure
  • Concerns about operative time
  • Unfamiliarity with newer ablation techniques
  • Focus on the primary surgical indication

However, these barriers can be small compared to the long-term consequences of leaving Afib with the patient.

Looking Forward: The Next 50 Years

Some medical experts have predicted that Afib and heart failure will dominate cardiovascular care for the next half-century.8 As our population ages and traditional risk factors become more prevalent, the importance of addressing these conditions together—not separately—will continue to grow.

Capitalizing on the Golden Opportunity

The vicious cycle created by Afib and heart failure together creates a call to action. Every day that Afib goes untreated, it's potentially accelerating damage to the heart and reducing cardiac output.

The good news? There are proven treatments that work.

The challenge? Working together to make sure they're offered and utilized.

If you have Afib or responsible for a patient with Afib are facing cardiac surgery, don't let this golden opportunity pass by to stop the progression.

 

Dr. Whitlock explains how establishing normal sinus rhythm has benefits in terms of heart failure outcomes.

PM-US-3652A-0825-G


  1. Carlisle, M.A., Fudim, M., DeVore, A. D., & Piccini, J. P. (2019). Heart failure and atrial fibrillation, like fire and fury. JACC: Heart Failure, 7(6):447-56.
  2. Fauchier, L. et al. (2016). Causes of death and influencing factors in patients with atrial fibrillation. The American Journal of Medicine, 129(12):1278-87.
  3. Mehaffey, J.H. et al. (2021). Barriers to atrial fibrillation ablation during mitral valve surgery. The Journal of Thoracic and Cardiovascular Surgery.
  4. McCarthy, P.M. et al. (2021). Surgery and Catheter Ablation for Atrial Fibrillation: History, Current Practice, and Future Directions. J Clin Med, 11(1):210, DOI: 10.3390/jcm11010210. PMID: 35011953; PMCID: PMC8745682.
  5. Gerdisch, M. (2022). The most beneficial options for patients with arrhythmia and concomitant structural heart disease: a review. AME Surgical Journal, 3, DOI:10.21037/asj-22-18.
  6. Lloyd-Jones, D.M. et al. (2004). Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation, 110(9):1042-46.
  7. Lloyd-Jones, D.M. et al. (2002). Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation, 106:3068-72
  8. Kotecha, D. & Piccini, J.P. (2015). Atrial fibrillation in heart failure: what should we do? Eur Heart J, 36(46):3250-7. DOI: 10.1093/eurheartj/ehv513. Epub 2015 Sep 28. PMID: 26419625; PMCID: PMC4670966.
  9. Boerschel, C. S. & Schnabel, R.B. (2019). The imminent epidemic of atrial fibrillation and its concomitant diseases–myocardial infarction and heart failure-a cause for concern. International Journal of Cardiology, 287:162-73.
  10. Odutayo, A. et al. (2016). Atrial fibrillation and risks of cardiovascular disease, renal disease, and deaths systematic review and meta analysis. BMJ 2016; 354:i4482.
  11. Musharbash, F.N. et al. (2018). Performance of the Cox-maze IV procedure is associated with improved long-term survival in patients with atrial fibrillation undergoing cardiac surgery. The Journal of Thoracic and Cardiovascular Surgery, 155(1):159-170.
PM-US-4853A-0827-G